Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China” (Letter)
Author(s)
Cavalcante, MB
Sarno, M
Araujo Júnior, E
Da Silva Costa, F
Barini, R
Griffith University Author(s)
Year published
2021
Metadata
Show full item recordAbstract
Dear Editor,
It was with great interest that we read and analyzed the letter to the editor of Xiang et al. The authors presented initial outcomes on the safety of lymphocyte immunotherapy (LIT) in a group of patients diagnosed with alloimmune recurrent miscarriage (RM) during November 1, 2019–January 17, 2020 in Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology.Dear Editor,
It was with great interest that we read and analyzed the letter to the editor of Xiang et al. The authors presented initial outcomes on the safety of lymphocyte immunotherapy (LIT) in a group of patients diagnosed with alloimmune recurrent miscarriage (RM) during November 1, 2019–January 17, 2020 in Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology.
View less >
View less >
Journal Title
Archives of Gynecology and Obstetrics
Volume
304
Issue
2
Subject
Immunology